Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 51

Sort by

Sort Order Select

Journal Articles

B Cell Precursor Lymphoblastic Leukemia Patients with Good Treatment Response Have Low Levels of Erythroid Precursors

Barbora Vakrmanova, MD, Michaela Novakova, Martina Vaskova, Iveta Janotová, Elena Vodickova, MD, Monika Brüggemann, Eva Fronkova, MD PhD, Jan Trka, MD PhD, Jan Stary, MD PhD, Ondrej Hrusak, Ester Mejstrikova, MD PhD

Blood (2018) 132 (Supplement 1): 2832.

https://doi.org/10.1182/blood-2018-99-117976

Published: 2018

Journal Articles

Switching Towards Monocytic Lineage and Discordancy between Flow Cytometric and PCR Minimal Residual Disease Results Is a Hallmark Feature of DUX4 Rearranged B-Cell Precursor Acute Lymphoblastic Leukemia

Michaela Novakova, Barbora Vakrmanova, MD, Lucie Slamova, Alena Musilova, Monika Brüggemann, Matthias Ritgen, MD, Eva Fronkova, MD PhD, Tomas Kalina, MD PhD, Jan Trka, MD PhD, Jan Stary, MD PhD, Martina Vaskova, Lucie Winkowska, Marketa Zaliova, Karel Fišer, PhD, Ondrej Hrusak, Ester Mejstrikova, MD PhD

Blood (2018) 132 (Supplement 1): 2825.

https://doi.org/10.1182/blood-2018-99-116575

Published: 2018

Journal Articles

Chromosome 21 Gain Is Dispensable for Transient Myeloproliferative Disorder (TMD) Development

Julius Lukes, Jr., MD, Eliska Potuckova, Julia Starkova, Jan Stary, MD PhD, Jan Zuna, Jan Trka, MD PhD, Marketa Zaliova

Blood (2018) 132 (Supplement 1): 2764.

https://doi.org/10.1182/blood-2018-99-112078

Published: 2018

Journal Articles

Folate-Dependent Normocytic Anemia Caused By a Hypomorphic Mutation in SLC19A1 gene

Michael Svaton, MD, Karolina Skvarova Kramarzova, MSc, PhD, Veronika Kanderova, MSc, PhD, Petr Smisek, MD, Pavel Jesina, MSc, MD, PhD, Jakub Krijt, MSc, Blanka Stiburkova, MSc, PhD, Andrea Mancikova, MSc, Robert Dobrovolny, MSc, PhD, Violeta Bakardjieva-Mihaylova, MSc, Elena Vodickova, MD, Jan Stuchly, MSc, Tomas Kalina, MD PhD, Jan Stary, MD PhD, Jan Trka, MD PhD, Eva Fronkova, MD PhD, Viktor Kozich, MD PhD

Blood (2018) 132 (Supplement 1): 502.

https://doi.org/10.1182/blood-2018-99-113501

Published: 2018

Journal Articles

Novel Recurrent Germline JAK2 G571S Variant in Childhood Acute B-Lymphoblastic Leukemia: A Double Hit One Pathway Scenario

Franziska Auer, PhD, Minhui Lin, PhD, Karin Nebral, PhD, Christoph G. W. Gertzen, PhD, Oskar A. Haas, MD, Michaela Kuhlen, MD, Holger Gohlke, PhD, Shai Izraeli, MD, Jan Trka, MD PhD, Jianda Hu, PhD, Arndt Borkhardt, MD, Julia Hauer, MD

Blood (2018) 132 (Supplement 1): 387.

https://doi.org/10.1182/blood-2018-99-115293

Published: 2018

Journal Articles

The Combination of MRD and Copy Number Alterations (CNAs) Defines an Ultra-High Risk Group of Children with Primary T-Lymphoblastic Leukemia (T-ALL)

Joachim B. Kunz, MD, Julia Seemann, Martin Zimmermann, PhD, Paulina Richter-Pechanska, Obul Reddy Bandapalli, PhD, Elena Orlova, Gunnar Cario, Martin Stanulla, MD, Martin Schrappe, MD PhD, Marketa Zaliova, Jan Trka, MD PhD, Renate Panzer-Grümayer, MD, Georg Mann, MD, Martina U. Muckenthaler, PhD, Jan O. Korbel, PhD, Andreas E Kulozik, MD PhD

Blood (2016) 128 (22): 2911.

https://doi.org/10.1182/blood.V128.22.2911.2911

Published: 2016

Journal Articles

DLX1 Affects Cell Cycle and Proliferation of Myeloid Leukemia Cells In Vitro and In Vivo

Katerina Rejlova, Miroslava Kardosova, Martina Slamova, Marketa Zaliova, Meritxell Alberich-Jorda, Jan Trka, MD PhD, Julia Starkova

Blood (2016) 128 (22): 1666.

https://doi.org/10.1182/blood.V128.22.1666.1666

Published: 2016

Journal Articles

NGS-Based Minimal Residual Disease (MRD) after Stem Cell Transplantation (SCT) Is More Specific for Relapse Prediction Than qPCR and Suggests the Possibility of False-Positive qPCR Results

Michaela Kotrova, MD, Vincent H.J. van der Velden, PhD, Jacques J.M. van Dongen, MD PhD, Renata Formankova, MD PhD, Petr Sedlacek, MD PhD, Monika Brüggemann, MD PhD, Jan Zuna, MD PhD, Jan Stary, MD, Jan Trka, MD PhD, Eva Fronkova, M. D., Ph. D.

Blood (2016) 128 (22): 3494.

https://doi.org/10.1182/blood.V128.22.3494.3494

Published: 2016

Journal Articles

The Role of Histone Demethylases and DNA Methyltransferases in the Transcription Regulation of HOX Genes in PML-RARa+ AML Patients

Katerina Rejlova, Alena Musilova, Martina Slamova, Karel Fiser, Karolina Skvarova Kramarzova, Marketa Zaliova, Jan Trka, MD PhD, Julia Starkova

Blood (2016) 128 (22): 3921.

https://doi.org/10.1182/blood.V128.22.3921.3921

Published: 2016

Journal Articles

L-Asparaginase Causes Metabolic Reprogramming in ALL Cells

Ivana Hermanova, Karel Valis, PhD, Hana Nuskova, Meritxell Alberich-Jorda, PhD, Amaia Arruabarrena Aristorena, Sonia Fernández-Ruiz, Simona Bartova, Alena Pecinova, PhD, Daniel Kavan, PhD, Karel Fiser, PhD, Marek Kuzma, PhD, Petr Novak, PhD, Tomas Mracek, PhD, Arkaitz Carracedo, PhD, Jan Trka, MD, PhD, Prof., Julia Starkova

Blood (2014) 124 (21): 922.

https://doi.org/10.1182/blood.V124.21.922.922

Published: 2014

Journal Articles

The Role of Histone Demethylases in the Transcription Regulation of HOX Genes in PML-RARa+ AML Patients

Katerina Rejlova, Karolina Kramarzova, PhD, Meritxell Alberich-Jorda, PhD, Karel Fiser, PhD, Marketa Zaliova, MD PhD, Jan Trka, MD, PhD, Prof., Julia Starkova

Blood (2014) 124 (21): 876.

https://doi.org/10.1182/blood.V124.21.876.876

Published: 2014

Journal Articles

Prediction of Relapse By microRNA Expression in Pediatric B-Lineage Acute Lymphoblastic Leukemia

Blood (2014) 124 (21): 3793.

https://doi.org/10.1182/blood.V124.21.3793.3793

Published: 2014

Journal Articles

Prognostic Value of Rare IKZF1 deletions in Childhood B-Cell Precursor Acute Lymphoblastic Leukemia: An International Collaborative Study

Blood (2014) 124 (21): 368.

https://doi.org/10.1182/blood.V124.21.368.368

Published: 2014

Journal Articles

IKZF1 deletions in Pediatric Acute Myeloid Leukemia

Jasmijn de Rooij, MD, Eva Beuling, PhD, C. Michel Zwaan, Askar Obulkasim, André Baruchel, MD, Jan Trka, MD PhD, Dirk Reinhardt, MD PhD, Edwin Sonneveld, PhD, Brenda Gibson, Martin Zimmermann, Rob Pieters, MD PhD, Marry van den Heuvel-Eibrink, MD PhD, Maarten Fornerod, PhD

Blood (2014) 124 (21): 2346.

https://doi.org/10.1182/blood.V124.21.2346.2346

Published: 2014

Journal Articles

Effective Response Metric (ERM-D8) Using Time-Series Gene Expression Profiling at Diagnosis and Day 8 of Remission-Induction Therapy Is a Novel Early Prognostic Marker to Predict Relapse in Childhood Acute Lymphoblastic Leukemia (ALL) — a Malaysia-Singapore ALL Study

Allen Eng Juh Yeoh, MD, Zhenhua Li, PhD, Difeng Dong, PhD, Yi Lu, PhD, Jan Trka, MD, PhD, Prof., Shirley Kow Yin Kham, B.Sc., Ah Moy Tan, MD, Hany Ariffin, MD, Limsoon Wong, PhD

Blood (2014) 124 (21): 2393.

https://doi.org/10.1182/blood.V124.21.2393.2393

Published: 2014

Journal Articles

Observational Study Alternating R-CHOP21 and R-Cytarabine (3+3 Cycles) for Patients with Newly Diagnosed Mantle Cell Lymphoma Not Eligible for High-Dose Therapy: A Czech Lymphoma Study Group Trial Preliminary Results

Pavel Klener, MD, PhD, Eva Fronkova, MD, PhD, Robert Pytlik, MD, PhD, Marketa Kalinova, D.Sc., PhD, Kristina Forsterova, D.Sc., PhD, David Belada, MD, Martin Simkovic, MD, David Salek, MD, PhD, Heidi Mocikova, MD, PhD, Vit Prochazka, MD, PhD, Vit Campr, MD, PhD, Radek Jaksa, MD, Jozef Kubinyi, MD, PhD, Jiri Dolezal, MD, PhD, Ass.Prof., Jan Trka, MD, PhD, Prof., Marek Trneny, MD, PhD, Prof.

Blood (2014) 124 (21): 1720.

https://doi.org/10.1182/blood.V124.21.1720.1720

Published: 2014

Journal Articles

ETV6 Aberrations Are a Recurrent Event in Pediatric Acute Myeloid Leukemia with Poor Clinical Outcome

Jasmijn de Rooij, MD, Eva Beuling, PhD, Maarten Fornerod, PhD, Askar Obulkasim, André Baruchel, MD, Jan Trka, MD, PhD, Prof., Dirk Reinhardt, MD PhD, Edwin Sonneveld, PhD, Martin Zimmermann, Rob Pieters, MD PhD, Marry van den Heuvel-Eibrink, MD PhD, C. Michel Zwaan, MD PhD

Blood (2014) 124 (21): 1012.

https://doi.org/10.1182/blood.V124.21.1012.1012

Published: 2014

Journal Articles

Microrna-106b~25 Cluster Is Involved in Relapsed MLL -Rearranged Pediatric AML

Lonneke Verboon, Maarten Fornerod, PhD, Askar Obulkasim, Edwin Sonneveld, PhD, André Baruchel, MD, Jan Trka, MD PhD, Dirk Reinhardt, MD PhD, Rob Pieters, MD PhD, Jacqueline Cloos, PhD, Gertjan JL Kaspers, MD PhD, Jan-Henning Klusmann, MD, C. Michel Zwaan, MD PhD, Marry van den Heuvel-Eibrink, MD PhD

Blood (2014) 124 (21): 1038.

https://doi.org/10.1182/blood.V124.21.1038.1038

Published: 2014

Journal Articles

Next Generation Amplicon Sequencing of Immunoglobulin Heavy Chain Gene Rearrangaments for Minimal Residual Disease (MRD) Stratification in Childhood Acute Lymphoblastic Leukemia (ALL): A Comparison with Classical qPCR-Based Technique

Michaela Kotrova, MD, Katerina Muzikova, M.Sc., Ester Mejstrikova, MD, PhD, Michaela Novakova, Violeta Bakardjieva-Mihaylova, M.Sc., Fiser Karel, PhD, Jan Stuchly, M.Sc., Christiane Pott, M..D, PhD, Monika Bruggemann, MD, PhD, Stary Jan, MD, D.Sc., Prof., Jan Trka, MD, PhD, Prof., Eva Fronkova, MD, PhD

Blood (2014) 124 (21): 2395.

https://doi.org/10.1182/blood.V124.21.2395.2395

Published: 2014

Journal Articles

NARROW

B Cell Precursor Lymphoblastic Leukemia Patients with Good Treatment Response Have Low Levels of Erythroid Precursors

Switching Towards Monocytic Lineage and Discordancy between Flow Cytometric and PCR Minimal Residual Disease Results Is a Hallmark Feature of DUX4 Rearranged B-Cell Precursor Acute Lymphoblastic Leukemia

Chromosome 21 Gain Is Dispensable for Transient Myeloproliferative Disorder (TMD) Development

Folate-Dependent Normocytic Anemia Caused By a Hypomorphic Mutation in SLC19A1 gene

Novel Recurrent Germline JAK2 G571S Variant in Childhood Acute B-Lymphoblastic Leukemia: A Double Hit One Pathway Scenario

The Combination of MRD and Copy Number Alterations (CNAs) Defines an Ultra-High Risk Group of Children with Primary T-Lymphoblastic Leukemia (T-ALL)

DLX1 Affects Cell Cycle and Proliferation of Myeloid Leukemia Cells In Vitro and In Vivo

NGS-Based Minimal Residual Disease (MRD) after Stem Cell Transplantation (SCT) Is More Specific for Relapse Prediction Than qPCR and Suggests the Possibility of False-Positive qPCR Results

The Role of Histone Demethylases and DNA Methyltransferases in the Transcription Regulation of HOX Genes in PML-RARa+ AML Patients

L-Asparaginase Causes Metabolic Reprogramming in ALL Cells

The Role of Histone Demethylases in the Transcription Regulation of HOX Genes in PML-RARa+ AML Patients

Prediction of Relapse By microRNA Expression in Pediatric B-Lineage Acute Lymphoblastic Leukemia

Prognostic Value of Rare IKZF1 deletions in Childhood B-Cell Precursor Acute Lymphoblastic Leukemia: An International Collaborative Study

IKZF1 deletions in Pediatric Acute Myeloid Leukemia

Effective Response Metric (ERM-D8) Using Time-Series Gene Expression Profiling at Diagnosis and Day 8 of Remission-Induction Therapy Is a Novel Early Prognostic Marker to Predict Relapse in Childhood Acute Lymphoblastic Leukemia (ALL) — a Malaysia-Singapore ALL Study

Observational Study Alternating R-CHOP21 and R-Cytarabine (3+3 Cycles) for Patients with Newly Diagnosed Mantle Cell Lymphoma Not Eligible for High-Dose Therapy: A Czech Lymphoma Study Group Trial Preliminary Results

ETV6 Aberrations Are a Recurrent Event in Pediatric Acute Myeloid Leukemia with Poor Clinical Outcome

Microrna-106b~25 Cluster Is Involved in Relapsed MLL -Rearranged Pediatric AML

Next Generation Amplicon Sequencing of Immunoglobulin Heavy Chain Gene Rearrangaments for Minimal Residual Disease (MRD) Stratification in Childhood Acute Lymphoblastic Leukemia (ALL): A Comparison with Classical qPCR-Based Technique

Low Levels of Mir-151-5p and Mir-451 Predict Relapse in Pediatric B-Lineage Acute Lymphoblastic Leukemia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only